Literature DB >> 22370458

Pediatric rheumatic disease: Treating lupus nephritis in children--is there a gold standard?

Rolando Cimaz.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 22370458     DOI： 10.1038/nrrheum.2012.19

Source DB:  PubMed          Journal:  Nat Rev Rheumatol        ISSN： 1759-4790            Impact factor:   20.543


× No keyword cloud information.
  10 in total

1.  Longterm followup of childhood lupus nephritis.

Authors:  Stefan Hagelberg; Yuna Lee; Joanne Bargman; Gordon Mah; Rayfel Schneider; Carl Laskin; Allison Eddy; Dafna Gladman; Murray Urowitz; Diane Hebert; Earl Silverman
Journal:  J Rheumatol       Date:  2002-12       Impact factor: 4.666

2.  Consensus treatment plans for induction therapy of newly diagnosed proliferative lupus nephritis in juvenile systemic lupus erythematosus.

Authors:  Rina Mina; Emily von Scheven; Stacy P Ardoin; B Anne Eberhard; Marilynn Punaro; Norman Ilowite; Joyce Hsu; Marisa Klein-Gitelman; L Nandini Moorthy; Eyal Muscal; Suhas M Radhakrishna; Linda Wagner-Weiner; Matthew Adams; Peter Blier; Lenore Buckley; Elizabeth Chalom; Gaëlle Chédeville; Andrew Eichenfield; Natalya Fish; Michael Henrickson; Aimee O Hersh; Roger Hollister; Olcay Jones; Lawrence Jung; Deborah Levy; Jorge Lopez-Benitez; Deborah McCurdy; Paivi M Miettunen; Ana I Quintero-del Rio; Deborah Rothman; Ornella Rullo; Natasha Ruth; Laura E Schanberg; Earl Silverman; Nora G Singer; Jennifer Soep; Reema Syed; Larry B Vogler; Ali Yalcindag; Cagri Yildirim-Toruner; Carol A Wallace; Hermine I Brunner
Journal:  Arthritis Care Res (Hoboken)       Date:  2012-03       Impact factor: 4.794

3.  Lupus: how much "complexity" is really (just) genetic heterogeneity?

Authors:  Yanick J Crow
Journal:  Arthritis Rheum       Date:  2011-12

4.  Differences in clinical manifestations between childhood-onset lupus and adult-onset lupus: a meta-analysis.

Authors:  B Livingston; A Bonner; J Pope
Journal:  Lupus       Date:  2011-09-27       Impact factor: 2.911

5.  Mycophenolic acid area under the curve correlates with disease activity in lupus patients treated with mycophenolate mofetil.

Authors:  Noël Zahr; Laurent Arnaud; Pierre Marquet; Julien Haroche; Nathalie Costedoat-Chalumeau; Jean-Sébastien Hulot; Christian Funck-Brentano; Jean-Charles Piette; Zahir Amoura
Journal:  Arthritis Rheum       Date:  2010-07

6.  Efficacy of rituximab in 164 patients with biopsy-proven lupus nephritis: pooled data from European cohorts.

Authors:  Cándido Díaz-Lagares; Sara Croca; Shirish Sangle; Edward M Vital; Fausta Catapano; Agustín Martínez-Berriotxoa; Francisco García-Hernández; José-Luis Callejas-Rubio; Javier Rascón; David D'Cruz; David Jayne; Guillermo Ruiz-Irastorza; Paul Emery; David Isenberg; Manuel Ramos-Casals; Munther A Khamashta
Journal:  Autoimmun Rev       Date:  2011-10-18       Impact factor: 9.754

7.  Three decades of progress in treating childhood-onset lupus nephritis.

Authors:  Tanya Pereira; Carolyn L Abitbol; Wacharee Seeherunvong; Chryso Katsoufis; Jayanthi Chandar; Michael Freundlich; Gastón Zilleruelo
Journal:  Clin J Am Soc Nephrol       Date:  2011-07-28       Impact factor: 8.237

8.  TLR recognition of self nucleic acids hampers glucocorticoid activity in lupus.

Authors:  Cristiana Guiducci; Mei Gong; Zhaohui Xu; Michelle Gill; Damien Chaussabel; Thea Meeker; Jean H Chan; Tracey Wright; Marilynn Punaro; Silvia Bolland; Vassili Soumelis; Jacques Banchereau; Robert L Coffman; Virginia Pascual; Franck J Barrat
Journal:  Nature       Date:  2010-06-17       Impact factor: 49.962

9.  Induction therapy for pediatric focal proliferative lupus nephritis: cyclophosphamide versus mycophenolate mofetil.

Authors:  Keith K Lau; Bettina H Ault; Deborah P Jones; Lavjay Butani
Journal:  J Pediatr Health Care       Date:  2008-03-04       Impact factor: 1.812

10.  Mycophenolate mofetil versus cyclophosphamide for induction treatment of lupus nephritis.

Authors:  Gerald B Appel; Gabriel Contreras; Mary Anne Dooley; Ellen M Ginzler; David Isenberg; David Jayne; Lei-Shi Li; Eduardo Mysler; Jorge Sánchez-Guerrero; Neil Solomons; David Wofsy
Journal:  J Am Soc Nephrol       Date:  2009-04-15       Impact factor: 10.121
  10 in total
  2 in total

Review 1.  The treatment of systemic lupus proliferative nephritis.

Authors:  Marilynn G Punaro
Journal:  Pediatr Nephrol       Date:  2012-11-22       Impact factor: 3.714

2.  Lupus nephritis in children - 10 years' experience.

Authors:  Hanna Szymanik-Grzelak; Elżbieta Kuźma-Mroczkowska; Jadwiga Małdyk; Małgorzata Pańczyk-Tomaszewska
Journal:  Cent Eur J Immunol       Date:  2016-10-25       Impact factor: 2.085
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.